Agios

Agios is a commercial-stage biopharmaceutical company. The company’s vision is to redefine the future of rare disease treatment. With a foundation in hematology, Agios combines biological expertise and real-world insights to advance a growing pipeline of rare disease medicines that reflect the priorities of the people it serves.

Visit www.agios.com.